Development & Screening Approach for Lipid Nanoparticle: A Review
Keywords:
Nanoparticle, Lipid Nanoparticle, SLN, NLC, Screening ApproachAbstract
Since the beginning of the 1990s the lipid nanoparticles were getting a growing interest from the pharmaceutical technology research group’s world wide. Nowadays solid lipid nanoparticles (SLN), nanostructured lipid carriers (NLC) and lipid drug conjugate (LDC) have been already investigated as carrier systems for many applications. This review article explains what was the need to develop new concept for lipid Nanoparticle. SLN have a lot of problem like drug loading as well as drug expulsion on long time storage due to β modification of solid lipid, To overcome this NLC were developed. SLN & NLC are basically use for loading of hydrophobic drug where LDC developed to overcome such problem. The approach used to select the solid as well as liquid lipid were discus in this article which help in selecting appropriate lipid for formulation of lipid Nanoparticle.
Downloads
Published
How to Cite
Issue
Section
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).